# Trial of Dextromethorphan in Rett Syndrome

> **NCT00593957** · PHASE2 · TERMINATED · sponsor: **Hugo W. Moser Research Institute at Kennedy Krieger, Inc.** · enrollment: 38 (actual)

## Conditions studied

- Rett Syndrome

## Interventions

- **DRUG:** Dextromethorphan
- **DRUG:** Dextromethorphan

## Key facts

- **NCT ID:** NCT00593957
- **Lead sponsor:** Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-08
- **Primary completion:** 2010-04
- **Final completion:** 2010-06
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** Study changed to a placebo controlled trial of dextromethorphan
- **Last updated:** 2014-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00593957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00593957, "Trial of Dextromethorphan in Rett Syndrome". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00593957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*